198 related articles for article (PubMed ID: 32650484)
1. Simultaneous FTIR and Raman Spectroscopy in Endometrial Atypical Hyperplasia and Cancer.
Barnas E; Skret-Magierlo J; Skret A; Kaznowska E; Depciuch J; Szmuc K; Łach K; Krawczyk-Marć I; Cebulski J
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32650484
[TBL] [Abstract][Full Text] [Related]
2. Spectroscopic evaluation of carcinogenesis in endometrial cancer.
Depciuch J; Barnaś E; Skręt-Magierło J; Skręt A; Kaznowska E; Łach K; Jakubczyk P; Cebulski J
Sci Rep; 2021 Apr; 11(1):9079. PubMed ID: 33907297
[TBL] [Abstract][Full Text] [Related]
3. New concepts for an old problem: the diagnosis of endometrial hyperplasia.
Sanderson PA; Critchley HO; Williams AR; Arends MJ; Saunders PT
Hum Reprod Update; 2017 Mar; 23(2):232-254. PubMed ID: 27920066
[TBL] [Abstract][Full Text] [Related]
4. A New Hysteroscopic Risk Scoring System for Diagnosing Endometrial Hyperplasia and Adenocarcinoma.
Ianieri MM; Staniscia T; Pontrelli G; Di Spiezio Sardo A; Manzi FS; Recchi M; Liberati M; Ceccaroni M
J Minim Invasive Gynecol; 2016; 23(5):712-8. PubMed ID: 26940400
[TBL] [Abstract][Full Text] [Related]
5. Hysteroscopic view in atypical endometrial hyperplasias: A correlation with pathologic findings on hysterectomy specimens.
Garuti G; Mirra M; Luerti M
J Minim Invasive Gynecol; 2006; 13(4):325-30. PubMed ID: 16825075
[TBL] [Abstract][Full Text] [Related]
6. Could E-Cadherin and CD10 Expression be Used to Differentiate Between Atypical Endometrial Hyperplasia and Endometrial Carcinoma?
Youssef MY; Mohamed MA
Int J Gynecol Pathol; 2019 Mar; 38(2):128-137. PubMed ID: 30726192
[TBL] [Abstract][Full Text] [Related]
7. AgNORs in endometrial lesions.
Kaushik R; Sharma S; Mahajan V; Gulati A; Sharma BB
Indian J Pathol Microbiol; 1999 Oct; 42(4):451-4. PubMed ID: 11127377
[TBL] [Abstract][Full Text] [Related]
8. [An analysis on the clinicopathological characteristics of 79 cases atypical endometrial hyperplasia].
Wang ZQ; Yang XQ; Wang JL; Xie JL; Shen DH; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):19-23. PubMed ID: 21429429
[TBL] [Abstract][Full Text] [Related]
9. [Difficulties and mistakes in the diagnosis of atypical endometrial hyperplasia].
Kxmel'nitskaia NM; Neĭshtadt EL; Khalimdzhanov ZK
Arkh Patol; 2006; 68(6):39-42. PubMed ID: 17290894
[TBL] [Abstract][Full Text] [Related]
10. Paired boxed gene 1 expression: A single potential biomarker for differentiating endometrial lesions associated with favorable outcomes in patients with endometrial carcinoma.
Liu LC; Lai HC; Chou YC; Huang RL; Yu MH; Lin CP; Tsai WC; Chiang KJ; Wang YC; Chao TK
J Obstet Gynaecol Res; 2016 Sep; 42(9):1159-67. PubMed ID: 27226215
[TBL] [Abstract][Full Text] [Related]
11. Practical usefulness of atypical endometrial cell categories within the new classification of endometrial cytology when applied to conventional smears.
Munakata S; Sasaki S; Takase M; Okatake R; Suzuki Y; Yamamoto T; Yanoh K
Cytopathology; 2017 Apr; 28(2):131-139. PubMed ID: 27859783
[TBL] [Abstract][Full Text] [Related]
12. Inter-observer reproducibility of endometrial cytology by the Osaki Study Group method: utilising the Becton Dickinson SurePath
Norimatsu Y; Yamaguchi T; Taira T; Abe H; Sakamoto H; Takenaka M; Yanoh K; Yoshinobu M; Irino S; Hirai Y; Kobayashi TK
Cytopathology; 2016 Dec; 27(6):472-478. PubMed ID: 27109167
[TBL] [Abstract][Full Text] [Related]
13. Ki-67 index as an ancillary tool in the differential diagnosis of proliferative endometrial lesions with secretory change.
Gurda GT; Baras AS; Kurman RJ
Int J Gynecol Pathol; 2014 Mar; 33(2):114-9. PubMed ID: 24487464
[TBL] [Abstract][Full Text] [Related]
14. Endometrial hyperplasia as a risk factor of endometrial cancer.
Nees LK; Heublein S; Steinmacher S; Juhasz-Böss I; Brucker S; Tempfer CB; Wallwiener M
Arch Gynecol Obstet; 2022 Aug; 306(2):407-421. PubMed ID: 35001185
[TBL] [Abstract][Full Text] [Related]
15. Expression of Glut-1 in Normal Endometrium and Endometrial Lesions: Analysis of 336 Cases.
Němejcová K; Rosmusová J; Bártů M; Důra M; Tichá I; Dundr P
Int J Surg Pathol; 2017 Aug; 25(5):389-396. PubMed ID: 28381136
[TBL] [Abstract][Full Text] [Related]
16. Liquid-based endometrial cytology: cyto-histological correlation in a population of 917 women.
Buccoliero AM; Gheri CF; Castiglione F; Garbini F; Barbetti A; Fambrini M; Bargelli G; Pappalardo S; Taddei A; Boddi V; Scarselli GF; Marchionni M; Taddei GL
Cytopathology; 2007 Aug; 18(4):241-9. PubMed ID: 17559564
[TBL] [Abstract][Full Text] [Related]
17. The ability of endometrial biopsies with atypical complex hyperplasia to guide surgical management.
Miller C; Bidus MA; Pulcini JP; Maxwell GL; Cosin JA; Rose GS
Am J Obstet Gynecol; 2008 Jul; 199(1):69.e1-4. PubMed ID: 18241812
[TBL] [Abstract][Full Text] [Related]
18. Detection of PTEN immunoreactivity in endometrial hyperplasia and adenocarcinoma.
Tantbirojn P; Triratanachat S; Trivijitsilp P; Niruthisard S
J Med Assoc Thai; 2008 Aug; 91(8):1161-5. PubMed ID: 18788685
[TBL] [Abstract][Full Text] [Related]
19. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.
Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K
Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755
[TBL] [Abstract][Full Text] [Related]
20. Clinical management of the status of atypical endometrial cells using the descriptive reporting format for endometrial cytology.
Nomura H; Sugiyama Y; Ito T; Furuta N; Komatsu K; Takazawa Y; Aoki Y; Tanigawa T; Matoda M; Okamoto S; Kanao H; Omatsu K; Kato K; Utsugi K; Takeshima N
Cytopathology; 2019 Mar; 30(2):209-214. PubMed ID: 30276929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]